Are Aviva shares still a buy to consider for their 5.9% dividend yield after climbing 28% this year?

Having more than doubled in price over the past five years, Andrew Mackie assesses the likelihood of further growth for Aviva shares.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

DIVIDEND YIELD text written on a notebook with chart

Image source: Getty Images

In the past 12 months, Aviva (LSE: AV.) shares have come alive and look to have finally managed to cast off the tag of being a ‘boring’ stock. However, with the share price now sitting at an 18-year high, the dividend yield has come down significantly. So are they still worth buying?

Q1 results

Looking at some of the headline numbers from its recent trading update, the insurance giant has picked up where it left off in 2024.

Its largest business, General Insurance, saw premiums rise by 9% to £2.9bn. Growth was strong both across personal and commercial lines.

The company’s partnership with Nationwide Building Society was a big driver for the 6% growth in UK personal lines premiums (eg car, home and travel). In commercial lines, the acquisition of Probitas, which provides it with access to the Lloyd’s of London insurance market, contributed toward the 17% growth.

Its portfolio is a majority-capital-light business today. Over the next two years it will be nearer 70% capital light. The acquisition of Direct Line Group will be a key driver of this increase as it unlocks synergies across the two businesses. At the moment the takeover’s being investigated by the Competition and Markets Authority. But I still expect the deal to be rubber stamped.

Dividend hikes

Over the past five years, Aviva’s returned £10bn in capital and dividends to shareholders. That represents about 62% of its current market-cap of £16bn. To me that highlights its shareholder-first approach to returns.

This year it intends to return two mid-single digit increases in the dividend cash cost. The first payment increase will reflect the organic growth across the business. Following the completion of the Direct Line Group deal, a second payment will be made. The total of these payouts is expected to more than offset the suspension of share buybacks in 2025.

From 2026, it expects to return to mid-single digit increase and to reinstate buybacks. The buybacks are important because the buyout deal will increase the total issued share capital.

Climate change

Hurricanes, floods, wildfires and other natural catastrophes linked to climate change present an emerging risk for Aviva.

Last year Canada, where it has a significant present, was the worst insured year for weather on record. Total losses for the insurance industry were over CA$8.5bn. These record losses fall on the heels of 2023 where Canadians made 8,000 claims across 17 natural catastrophes resulting in the business incurring losses of $200 million.

As these events become more frequent, the possibility of errors in underwriting leading to catastrophic losses can never be ruled out.

Despite such risks, there’s still so much to like about the business, not least huge growth opportunities across a number of its markets. The UK workplace pensions, advice and investments market are worth £1.8trn and growing at double digits. Insurance markets are growing rapidly too, off the back of growing populations and increasing requirements for commercial speciality insurance.

Consensus opinion across a group of analysts might indicate that the stock’s fairly priced today. But looking longer term, I remain optimistic about the prospects for the business. It remains one of my favoured picks and I intend to add to my position again soon.

Andrew Mackie has positions in Aviva Plc. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »